Optimizing Diabetes Treatment in Aging Populations: A Focus on Longevity, Life Quality, and Innovation

Abstract

The rapidly growing global population and rising prevalence of diabetes mellitus necessitate a reexamination of conventional diabetes management approaches, particularly for aging individuals. Older adults with diabetes face distinct physiological, cognitive, and social challenges that complicate standardized therapeutic models. Traditional treatment often emphasizes glycemic control—typically HbA1c targets—but this can lead to adverse effects such as hypoglycemia, polypharmacy, and a reduction in quality-of-life metrics, including functional independence, mental well-being, and daily activity levels. This article advocates for a patient-centered, geriatric-informed model that balances longevity with well-being. It promotes innovations such as telemedicine, wearable glucose monitors, simplified medication regimens, and interdisciplinary care teams to support personalized glycemic targets and improve quality of life. Additionally, the model emphasizes the integration of mental health support, mobility enhancement tools, and user-friendly technologies that accommodate age-related limitations. By shifting the focus to measurable outcomes like preserved autonomy, reduced hospitalization rates, and enhanced treatment adherence, this paradigm aims to provide more effective, sustainable, and equitable diabetes care for older adults. Policy and research directions must prioritize geriatric-inclusive trials, provider training, and expanded access to supportive innovations that address both clinical goals and quality-of-life dimensions.